Three U.S. Senators introduced new legislation last week in an effort to bolster treatment innovation by pharmaceutical companies for rare and neglected pediatric diseases. Sens. Sherrod Brown (D-OH), Sam Brownback (R-KS) and Al Franken (D-MN) proposed The Creating Hope Act of 2010 (S. 3697) in a bipartisan effort that builds on the FDA Amendments Act […]
HIV
From 2016 to 2017, 14% of people living with HIV in the United States did something to save money on the out-of-pocket costs of their prescription […]
Tuberculosis
Combatting MDR TB: Year three – Released four years ago, the federal National Action Plan for Combating Multidrug-Resistant Tuberculosis raised hopes that targets and strategies would […]
Research & Development
This year marks the close of a dynamic decade in global infectious disease research and responses that changed expectations of what humanity can accomplish toward making […]
Policy
Wuhan City in the Hubei Province of the People’s Republic of China is on the Yangtze River and is the most populous city in central China. […]